Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06212557 · ClinicalTrials.gov registry record · NA
KIOS Mobile App Evaluation
A NA study of Opioid Use Disorder, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT06212557: Recruiting NA study of Opioid Use Disorder, sponsored by The University of Texas Health Science Center at San Antonio.
NCT06212557 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 210 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06212557, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluation of a mobile medical app (KIOS) vs. treatment as usual for the treatment of opioid use disorder (OUD).
Primary Outcome
Measured by the number of days from the start of the 13-week intervention until the participant either leaves the trial, or completes the trial
Conditions Studied
Interventions
- DEVICE KIOS App
- BEHAVIORAL KIOS App education
- BEHAVIORAL Treatment as usual
Study Locations (1)
Texas
- University of Texas Health Science Center - Department of Psychiatry - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2024-05-02 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT06212557 shows while recruiting
NCT06212557 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which KIOS App is the first listed.
NCT06212557 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06212557 about?
NCT06212557 is a clinical study titled "KIOS Mobile App Evaluation". Evaluation of a mobile medical app (KIOS) vs. treatment as usual for the treatment of opioid use disorder (OUD).
What is the current status of trial NCT06212557?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2024-05-02. Estimated completion is 2026-05-31.
What conditions does trial NCT06212557 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT06212557?
The interventions under investigation include: KIOS App (DEVICE), KIOS App education (BEHAVIORAL), Treatment as usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT06212557?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06212557 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06212557's enrollment target sits among peer trials
210 88th of 257 higher than 170 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI